Can zinc help fight sepsis? early study explores dosing
NCT ID NCT01162109
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study looked at how the body handles zinc in people with severe sepsis, a life-threatening infection that causes organ failure. Researchers gave different doses of intravenous zinc to 40 ICU patients on breathing machines and compared them to 15 healthy volunteers. The goal was to find safe doses and understand how zinc affects inflammation and immune function, not to prove it works as a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Vermont College of Medicine
Burlington, Vermont, 05405, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking antibiotic levels in the blood improve sepsis care?
- Blood filtering may save children with sepsis
- Sepsis immune cell study ends early
- New blood marker could speed up sepsis diagnosis in emergency rooms
- Can less be more? study tests cutting back antibiotics in sepsis
- Massive data dive aims to tame sepsis in kids